[Clinical safety with ropivacaine administration].
Fornet Ruiz
I
I
Palacio Abizanda
F J
FJ
Gilsanz
F
F
D000328:Adult; D000577:Amides / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D015360:Analgesia, Epidural; D016362:Analgesia, Obstetrical; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D002045:Bupivacaine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D004487:Edema / Q000139:chemically induced; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous / Q000009:adverse effects*; D008431:Maternal-Fetal Exchange; D008508:Medication Errors / Q000009:adverse effects; D001523:Mental Disorders / Q000139:chemically induced; D007744:Obstetric Labor Complications / Q000139:chemically induced; D011247:Pregnancy; D000077212:Ropivacaine; D012449:Safety; D012640:Seizures / Q000139:chemically induced*; D014018:Tissue Distribution
D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine; D005283:Fentanyl; D002045:Bupivacaine